http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105950595-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-78
filingDate 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105950595-B
titleOfInvention (-)-gamma-lactam enzyme, gene, mutant, carrier and its preparation and application
abstract The present invention relates to a kind of (-)-gamma-lactam enzyme, its gene and mutant, recombinant expression plasmid and recombinant expression transformants containing the gene and mutant, the preparation of the recombination (-)-gamma-lactam enzyme, and should application of (-)-gamma-lactam enzyme in preparation (+)-gamma-lactam.Compared with prior art, (-)-gamma-lactam enzyme of the invention has the characteristics that enzymatic activity is high, concentration of substrate tolerance is good, preparing (+)-gamma-lactam using the enzymatic has the advantages such as reaction condition is mild, concentration of substrate is high, catalyst amount is few, therefore has a good application prospect in homocyclic nucleus glycoside pharmaceutical intermediate (+)-gamma-lactam industrial production.
priorityDate 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396417
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID51671
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID220674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453914681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1938
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID37329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31234
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID37329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441374
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID80866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451539483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474319
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID51671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3471145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557444
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21610435
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513869
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID80866

Total number of triples: 52.